Publikation
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
Wissenschaftlicher Artikel/Review - 07.11.2019
Heinhuis Kimberley M, Schilder Russell J, O'Byrne Kenneth, Curigliano Giuseppe, Romano Emanuela, Patah Poliana, Wang Rui, Liu Yali, Bajaj Gaurav, Britschgi Christian, Paz-Ares Luis, Carlino Matteo, Jörger Markus, Di Nicola Massimo, Meniawy Tarek, Rottey Sylvie, Moreno Victor, Gazzah Anas, Delord Jean-Pierre, Siu Lillian L
Heinhuis, Kimberley M
1
0
Carlino, Matteo
1
0
Jörger, Markus
Oberarzt Onkologie/HämatologieMitarbeiter Wissenschaftliche Module CTU (Klinische Pharmakologie)
Leitende(r) Arzt/Ärztin
Medizinische Onkologie und Hämatologie · Dept. I
175
43
Di Nicola, Massimo
1
0
Meniawy, Tarek
1
0
Rottey, Sylvie
1
0
Moreno, Victor
2
0
Gazzah, Anas
1
0
Delord, Jean-Pierre
1
0
Paz-Ares, Luis
3
0
Britschgi, Christian
6
0
Schilder, Russell J
1
0
O'Byrne, Kenneth
2
0
Curigliano, Giuseppe
3
0
Romano, Emanuela
1
0
Patah, Poliana
1
0
Wang, Rui
1
0
Liu, Yali
2
0
Bajaj, Gaurav
1
0
Siu, Lillian L
1
0